Have a feature idea you'd love to see implemented?
Let us know!
AMED Amedisys Inc
Price (delayed)
$90.49
Market cap
$2.96B
P/E Ratio
35.63
Dividend/share
N/A
EPS
$2.54
Enterprise value
$3.19B
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients,
Highlights
The P/E is 74% below the 5-year quarterly average of 139.1
The quick ratio has increased by 27% YoY and by 4.7% QoQ
AMED's EPS is down by 10% from the previous quarter
The net income has decreased by 10% QoQ
Key stats
What are the main financial stats of AMED
Market
Valuations
Earnings
Shares outstanding
32.75M
Market cap
$2.96B
Enterprise value
$3.19B
Price to earnings (P/E)
35.63
Price to book (P/B)
2.58
Price to sales (P/S)
1.28
EV/EBIT
19.09
EV/EBITDA
14.07
EV/Sales
1.37
Revenue
$2.32B
Gross profit
$1.01B
Net income
$82.93M
EBIT
$166.9M
EBITDA
$226.41M
Free cash flow
$204.4M
Per share
Balance sheet
Liquidity
EPS
$2.54
EPS diluted
$2.52
Free cash flow per share
$6.24
Book value per share
$35.06
Revenue per share
$70.88
TBVPS
$24.27
Total assets
$2.14B
Total liabilities
$938.68M
Debt
$467.67M
Equity
$1.15B
Working capital
$93.93M
Debt to equity
0.41
Current ratio
1.19
Quick ratio
1.12
Net debt/EBITDA
0.98
Margins
Efficiency
Dividend
EBITDA margin
9.8%
Gross margin
43.7%
Net margin
3.6%
Operating margin
6.4%
Return on assets
3.9%
Return on equity
7.5%
Return on invested capital
28.4%
Return on capital employed
10.1%
Return on sales
7.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMED stock price
How has the Amedisys stock price performed over time
Intraday
0.59%
1 week
6.37%
1 month
-1.01%
1 year
-4.81%
YTD
-4.81%
QTD
-6.24%
Financial performance
How have Amedisys's revenue and profit performed over time
Revenue
$2.32B
Gross profit
$1.01B
Operating income
$148.17M
Net income
$82.93M
Gross margin
43.7%
Net margin
3.6%
The company's operating margin fell by 16% YoY and by 9% QoQ
AMED's operating income is down by 12% year-on-year and by 7% since the previous quarter
The company's net margin fell by 10% QoQ
The net income has decreased by 10% QoQ
Growth
What is Amedisys's growth rate over time
Valuation
What is Amedisys stock price valuation
P/E
35.63
P/B
2.58
P/S
1.28
EV/EBIT
19.09
EV/EBITDA
14.07
EV/Sales
1.37
The P/E is 74% below the 5-year quarterly average of 139.1
AMED's EPS is down by 10% from the previous quarter
The P/B is 55% less than the 5-year quarterly average of 5.7 and 8% less than the last 4 quarters average of 2.8
AMED's equity is up by 10% year-on-year and by 2% since the previous quarter
The P/S is 44% less than the 5-year quarterly average of 2.3 and 9% less than the last 4 quarters average of 1.4
Amedisys's revenue has increased by 4.2% YoY
Efficiency
How efficient is Amedisys business performance
The ROIC has soared by 120% YoY but it has contracted by 2.4% from the previous quarter
AMED's ROS has soared by 95% YoY but it is down by 6% from the previous quarter
The ROE has contracted by 12% from the previous quarter
The ROA has declined by 11% since the previous quarter
Dividends
What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMED.
Financial health
How did Amedisys financials performed over time
AMED's total assets is 128% higher than its total liabilities
The quick ratio has increased by 27% YoY and by 4.7% QoQ
The current ratio has increased by 19% YoY and by 2.6% QoQ
The company's debt is 59% lower than its equity
The debt to equity has contracted by 13% YoY and by 2.4% from the previous quarter
AMED's equity is up by 10% year-on-year and by 2% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.